Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases

Abidemi Adegbola, Luke A. Bury, Chen Fu, Meixiang Zhang, Anthony Wynshaw-Boris

Research output: Contribution to journalReview articlepeer-review

18 Scopus citations


The major neuropsychiatric conditions of schizophrenia, affective disorders, and infantile autism are characterized by chronic symptoms of episodic, stable, or progressive nature that result in significant morbidity. Symptomatic treatments are the mainstay but do not resolve the underlying disease processes, which are themselves poorly understood. The prototype psychotropic drugs are of variable efficacy, with therapeutic mechanisms of action that are still uncertain. Thus, neuropsychiatric disorders are ripe for new technologies and approaches with the potential to revolutionize mechanistic understanding and drive the development of novel targeted treatments. The advent of methods to produce patient-derived stem cell models and three-dimensional organoids with the capacity to differentiate into neurons and the various neuronal cellular lineages mark such an advance. We discuss numerous techniques involved, their applications, and areas that require further optimization. Stem Cells Translational Medicine 2017;6:2062–2070.

Original languageEnglish
Pages (from-to)2062-2070
Number of pages9
JournalStem cells translational medicine
Issue number12
StatePublished - Dec 2017
Externally publishedYes


  • Cell biology
  • Induced pluripotent stem cells
  • Nervous system
  • Reprogramming


Dive into the research topics of 'Concise Review: Induced Pluripotent Stem Cell Models for Neuropsychiatric Diseases'. Together they form a unique fingerprint.

Cite this